Surviving childhood cancer may have consequences for young women
the ONA take:
According to a new study published in the Journal of Clinical Oncology, women that survived childhood cancer have decreased sexual functioning compared with their sisters that did not have cancer.
Those who were diagnosed with cancer as teenagers, had radiation therapy of the brain, or had stopped menstruating at a younger age had the highest risk for sexual dysfunction as adults.
Lead investigator Jennifer S. Ford of Memorial Sloan-Kettering Cancer Center in New York was surprised to see these effects many years after treatment. Out of 2,178 women with an average age of 29 who had been diagnosed with cancer before age 21, 30% reported not not being sexually active within the last month while 17% of 408 of their sisters had not been.
Among non-sexually active women, survivors were two times more likely to say they were not interested in sex, too tired, or had a physical problem with sex. Survivors were also less likely to have a current sexual partner or to be married.
Researchers suggest that the cancer or cancer therapy may have caused physical changes, as well as social and emotional ramifications. Patients should therefore be aware that their cancer or their cancer therapy may affect sex and that talking about the effects can be beneficial.
Adult women who survived cancer as a child report having less sex, less interest and less desire.
“These women are functioning really well, by and large, but there's this sliver of an issue that needs to be looked at more closely,” said lead author Jennifer S. Ford. Women who had been diagnosed as teens, been treated with radiation of the brain or who ceased menstruating at a younger age (or never began) were at the biggest risk for sexual dysfunction.
“One of the most surprising things was to find this impairment many, many years after treatment,” Ford told Reuters Health by phone. “You might expect things would go back to normal, but they did not.”
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|